X4 Pharmaceuticals's total assets for Q1 2026 were $270.28M, a decrease of -6.95% from the previous quarter. XFOR total liabilities were $101.83M for the fiscal quarter, a -2.25% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.